|
Mechanistic Insights and Therapeutic Strategies for HFpEF |
05/05/2021 - 12:00pm EDT to 05/05/2022 - 1:00pm EDT |
|
Mechanisms of Cardiovascular Toxicity Associated with Immunotherapeutics |
10/13/2021 - 12:00pm to 1:00pm EDT |
|
Management of the Competitive Athlete in the aftermath of SARS CoV-2 Infection |
09/15/2021 - 12:00pm EDT to 09/15/2022 - 1:00pm EDT |
|
Lymphatic Dysregulation with Heart Failure |
09/08/2021 - 12:00pm EDT to 09/08/2022 - 1:00pm EDT |
|
Left Ventricular Remodeling and Reverse Remodeling: Implications for Drug and Device Development in Heart Failure |
12/22/2021 - 12:00pm to 1:00pm EST |
|
Infectious Endocarditis |
12/09/2020 - 12:00pm EST to 12/09/2021 - 1:00pm EST |
|
Infectious Endocarditis |
12/09/2021 - 12:00pm EST to 12/09/2022 - 1:00pm EST |
|
How to integrate fthe findings of the ischemia trial in to the management of stabel CAD |
06/16/2021 - 12:00pm EDT to 06/16/2022 - 1:00pm EDT |
|
Heparin Resistance: Clinical Perceptive and Management strategies |
12/01/2021 - 12:00pm to 1:00pm EST |
|
Gene Editing For The treatment of Transthyretin Amyloidosis |
11/10/2021 - 12:00pm to 1:00pm EST |
Facebook
Twitter
LinkedIn
Forward